Abbott Receives FDA Clearance and CE Mark for Ultreon™ 3.0 AI-powered Coronary Imaging Platform

Abbott has received FDA clearance and CE Mark for its Ultreon™ 3.0 software, an AI-powered platform that enhances coronary imaging and provides automated insights to improve patient outcomes during percutaneous coronary intervention (PCI) procedures. The technology utilizes optical coherence tomography (OCT) for real-time guidance, helping physicians plan more effective treatments for blocked heart arteries.